Update on insulin treatment of dogs and cats with non-complicated diabetes mellitus

PDF (English)
Publicado: Jan 29, 2018
DOI: https://doi.org/10.12681/jhvms.15625
M. N. SARIDOMICHELAKIS
Clinic of Medicine, Faculty of Veterinary Science, University of Thessaly
M. K. CHATZIS
Clinic of Medicine, Faculty of Veterinary Science, University of Thessaly
Resumen

Diabetes mellitus is a common endocrine disease of dogs and cats. Treatment is mainly based on insulin administration and dietary modifications. The aim of this review is to provide updated information on insulin treatment of dogs and cats with non-complicated diabetes mellitus. During the last years, there has been significant progress in the management of this disease, thanks to the use of long-acting insulin preparations that do not cause pronounced fluctuations of blood glucose concentrations (insulin glargin and detemir) and because of the widespread use of home glucose monitoring by the owners of diabetic pets. Home glucose monitoring is based on capillary blood sampling from the ear pinnae or the foot pad and measurement of blood glucose concentration with a portable blood glucose meter. This can be done periodically (e.g. every week) to replace the traditional in-clinic blood glucose curve; in this case, blood glucose concentration is measured just before the morning insulin administration and then every 1-2 hours until the next dose (usually for 12 hours). Furthermore, especially for the cat, home glucose monitoring can be performed 3-5 times per day, on a daily basis, in order to safely adjust insulin dose and achieve tight control of hyperglycemia (i.e. blood glucose concentration between 50 and 200 mg dl-1 throughout the day). The combination of dietary management, of insulin glargine or detemir administration and of the tight control of hyperglycemia has substantially increased the proportion of cats that enter into temporal or permanent diabetic remission and can be further managed without insulin. Another important achievement is the use of continuous glucose monitoring systems to monitor interstitial fluid glucose concentrations. These devices can be used in the clinic and at home and they can measure glucose concentration every 5 minutes for up to 72 consecutive hours, thus facilitating optimal adjustment of insulin treatment.

Article Details
  • Sección
  • Review Articles
Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.

Authors who publish with this journal agree to the following terms:

· Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

· Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

· Authors are permitted and encouraged to post their work online (preferably in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Descargas
Los datos de descargas todavía no están disponibles.
Citas
Affenzeller N, Benesch T, Thalhammer JG, Willmann M (2010) A pilot study to evaluate a novel subcutaneous continuous glucose monitoring system in healthy Beagle dogs. Vet J 184: 105-110.
Affenzeller N, Thalhammer JG, Willmann M (2011) Home-based subcutaneous continuous glucose monitoring in 10 diabetic dogs. Vet Rec 169: 206.
Alt N, Kley S, Haessig M, Reusch CE (2007) Day-to-day variability of blood glucose concentration curves generated at home in cats with diabetes mellitus. J Am Vet Med Assoc 230: 1011-1017.
Aptekmann KP, Schwartz DS (2011) A survey of owner attitudes and experiences in managing diabetic dogs. Vet J 190: e122-124.
Athanasiou LV, Tsokana CN, Saridomichelakis MN (2014) Glucose measurement using portable blood glucose meters in dogs and cats. J Hell Vet Med Socaccepted for publication.
Callegari C, Mercuriali E, Hafner M, Coppola LM, Guazzetti S, Lutz TA, Reusch CE, Zini E (2013) Survival time and prognostic factors in cats with newly diagnosed diabetes mellitus: 114 cases (2000-2009). J Am Vet Med Assoc 243: 91-95.
Caney SM (2013) Management of cats on Lente insulin: tips and traps. Vet Clin North Am Small Anim Pract 43: 267-282.
Clark M, Thomaseth K, Heit M, Hoenig M (2012) Pharmacokinetics and pharmacodynamics of protamine zinc recombinant human insulin in healthy dogs. J Vet Pharmacol Ther 35: 342-350.
Cook AK (2007) The latest management recommendations for cats and dogs with nonketotic diabetes mellitus. Vet Med 54: 600-614.
Davison LJ, Walding B, Herrtage ME, Catchpole B (2008) Anti-insulin antibodies in diabetic dogs before and after treatment with different insulin preparations. J Vet Intern Med 22: 1317-1325.
Dietiker-Moretti S, Müller C, Sieber-Ruckstuhl N, Tschuor F, Osto M, Franchini M, Ackermann M, Lutz TA, Reusch CE, Zini E (2011) Comparison of a continuous glucose monitoring system with a portable blood glucose meter to determine insulin dose in cats with diabetes mellitus. J Vet Intern Med 25: 1084-1088.
Dunning MD, Lowrie CS, Bexfield NH, Dobson JM, Herrtage ME (2009) Exogenous insulin treatment after hypofractionated radiotherapy in cats with diabetes mellitus and acromegaly. J Vet Intern Med 23: 243-249.
Fleeman LM (2011) Continuous monitoring of glucose concentration in diabetic dogs. Vet Rec 169: 204-205.
Fleeman LM, Rand JS, Morton JM (2009) Pharmacokinetics and pharmacodynamics of porcine insulin zinc suspension in eight diabetic dogs. Vet Rec 164: 232-237.
Ford SL, Lynch H (2013) Practical use of home blood glucose monitoring in feline diabetics. Vet Clin North Am Small Anim Pract43: 283-301.
Fracassi F, Boretti FS, Sieber-Ruckstuhl NS, Reusch CE (2012) Use of insulin glargine in dogs with diabetes mellitus. Vet Rec 170: 52.
Gilor C, Ridge TK, Attermeier KJ, Graves TK (2010) Pharmacodynamics of insulin detemir and insulin glargine assessed by an isoglycemic clamp method in healthy cats. J Vet Intern Med 24: 870-874.
Gottlieb S, Rand JS (2013) Remission in cats: including predictors and risk factors. Vet Clin North Am Small Anim Pract 43: 245-249.
Hafner M, Lutz TA, Reusch CE, Zini E (2013) Evaluation of sensor sites for continuous glucose monitoring in cats with diabetes mellitus. J Feline Med Surg 15: 117-123.
Hall TD, Mahony O, Rozanski EA, Freeman LM (2009) Effects of diet on glucose control in cats with diabetes mellitus treated with twice daily insulin glargine. J Feline Med Surg 11: 125-130.
Hess RS, Drobatz KJ (2013) Glargine insulin for treatment of naturally occurring diabetes mellitus in dogs. J Am Vet Med Assoc 243: 1154-1161.
Hoenig M, Pach N, Thomaseth K, Devries F, Ferguson DC (2012) Evaluation of long-term glucose homeostasis in lean and obese cats by use of continuous glucose monitoring. Am J Vet Res 73: 1100-1106.
Maggiore AD, Nelson RW, Dennis J, Johnson E, Kass PH (2012) Efficacy of protamine zinc recombinant human insulin for controlling hyperglycemia in dogs with diabetes mellitus. J Vet Intern Med 26: 109-115.
Marshall RD, Rand JS, Morton JM (2008) Glargine and protamine zinc insulin have a longer duration of action and result in lower mean daily glucose concentrations than lente insulin in healthy cats. J Vet Pharmacol Ther 31: 205-212.
Marshall RD, Rand JS, Morton JM (2009) Treatment of newly diagnosed diabetic cats with glargine insulin improves glycaemic control and results in higher probability of remission than protamine zinc and lente insulins. J Feline Med Surg 11: 683-691.
Martin GJ, Rand JS (2007a) Comparisons of different measurements for monitoring diabetic cats treated with porcine insulin zinc suspension. Vet Rec 161: 52-58.
Martin GJ, Rand JS (2007b) Control of diabetes mellitus in cats with porcine insulin zinc suspension. Vet Rec 161: 88-94.
Miceli DD, Gallelli MF, Cabrera Blatter MF, Martiarena B, Brañas MM, Ortemberg LR, Gómez NV, Castillo VA (2012) Low dose of insulin detemir controls glycaemia, insulinemia and prevents diabetes mellitus progression in the dog with pituitary-dependent hyperadrenocorticism. Res Vet Sci 93: 114-120.
Michiels L, Reusch CE, Boari A, Petrie G, Mandigers P, Thollot IG, Rosenberg D, Mooney C, Bonfanti U, Font A, Sparkes A, Bewig K, Clercx C, Jensen AL, Horspool LJ (2008) Treatment of 46 cats with porcine lente insulin-a prospective, multicentre study. J Feline Med Surg 10: 439-451.
Moretti S, Tschuor F, Osto M, Franchini M, Wichert B, Ackermann M, Lutz TA, Reusch CE, Zini E (2010) Evaluation of a novel real-time continuous glucose-monitoring system for use in cats. J Vet Intern Med 24: 120-126.
Mori A, Kurishima M, Oda H, Saeki K, Arai T, Sako T (2013) Comparison of glucose fluctuations between day- and night-time measured using a continuous glucose monitoring system in diabetic dogs. J Vet Med Sci 75: 113-117.
Mori A, Sako T, Lee P, Motoike T, Iwase K, Kanaya Y, Fukuta H, Mizutani H, Arai T (2008) Comparison of time-action profiles of insulin glargine and NPH insulin in normal and diabetic dogs. Vet Res Commun 32: 563-573.
Nelson RW, Henley K, Cole C, Group. PCS (2009) Field safety and efficacy of protamine zinc recombinant human insulin for treatment of diabetes mellitus in cats. J Vet Intern Med 23: 787-793.
Niessen SJ, Powney S, Guitian J, Niessen AP, Pion PD, Shaw JA, Church DB (2010) Evaluation of a quality-of-life tool for cats with diabetes mellitus. J Vet Intern Med 24: 1098-1105.
Niessen SJ, Powney S, Guitian J, Niessen AP, Pion PD, Shaw JA, Church DB (2012) Evaluation of a quality-of-life tool for dogs with diabetes mellitus. J Vet Intern Med 26: 953-961.
Palm CA, Boston RC, Refsal KR, Hess RS (2009) An investigation of the action of Neutral Protamine Hagedorn human analogue insulin in dogs with naturally occurring diabetes mellitus. J Vet Intern Med 23: 50-55.
Rios L, Ward C (2008) Feline diabetes mellitus: diagnosis, treatment, and monitoring. Comp Cont Educ Pract 30: 626-640.
Roomp K, Rand J (2009) Intensive blood glucose control is safe and effective in diabetic cats using home monitoring and treatment with glargine. J Feline Med Surg 11: 668-682.
Roomp K, Rand J (2012) Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control. J Feline Med Surg 14: 566-572.
Roomp K, Rand JS (2013) Management of diabetic cats with long-acting insulin. Vet Clin North Am Small Anim Pract 43: 251-266.
Sako T, Mori A, Lee P, Oda H, Saeki K, Miki Y, Kurishima M, Mimura K, Nozawa S, Mizutani H, Makino Y, Ishioka K, Arai T (2011) Time-action profiles of insulin detemir in normal and diabetic dogs. Res Vet Sci 90: 396-403.
Scott-Moncrieff JC, Moore GE, Coe J, Lynn RC, Gwin W, Petzold R (2012) Characteristics of commercially manufactured and compounded protamine zinc insulin. J Am Vet Med Assoc 240: 600-605.
Sieber-Ruckstuhl NS, Kley S, Tschuor F, Zini E, Ohlerth S, Boretti FS, Reusch CE (2008) Remission of diabetes mellitus in cats with diabetic ketoacidosis. J Vet Intern Med 22: 1326-1332.
Smith JR, Vrono Z, Rapoport GS, Turek MM, Creevy KE (2012) A survey of southeastern United States veterinarians’ preferences for managing cats with diabetes mellitus. J Feline Med Surg 14: 716-722.
Surman S, Fleeman L (2013) Continuous glucose monitoring in smallanimals. Vet Clin North Am Small Anim Pract 43: 381-406.
Tschuor F, Zini E, Schellenberg S, Wenger M, Kaufmann K, Furrer D, Lutz TA, Reusch CE (2011) Remission of diabetes mellitus in cats cannot be predicted by the arginine stimulation test. J Vet Intern Med 25: 83-89.
Wiedmeyer CE, DeClue AE (2008) Continuous glucose monitoring in dogs and cats. J Vet Intern Med 22: 2-8.
Zerrenner D, Peterson M, Crawford MA (2007) The evolution of insulin therapy. Comp Cont Educ Pract 29: 522-535.
Zini E, Hafner M, Osto M, Franchini M, Ackermann M, Lutz TA, Reusch CE (2010) Predictors of clinical remission in cats with diabetes mellitus. J Vet Intern Med 24: 1314-1321.